Literature DB >> 16514322

Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome.

Christian Schinkel1, Andreas Gaertner, Johannes Zaspel, Siegfried Zedler, Eugen Faist, Matthias Schuermann.   

Abstract

OBJECTIVES: Complex regional pain syndrome type 1 (CRPS 1) is a disorder that can affect an extremity after minor trauma or surgery. The pathogenesis of this syndrome is unclear. It has clinical signs of severe local inflammation as a result of an exaggerated inflammatory response, but neurogenic dysregulation also may contribute to it.
METHODS: For further insights into the pathogenesis of CRPS 1, the authors investigated inflammatory and neurogenic mediators-C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-8 (IL-8), soluble tumor necrosis factor receptor I/II (sTNFR I/II), sE-selectin, sL-selectin, sP-selectin, substance P, neuropeptide Y, and calcitonin gene-related peptide-in venous blood from both the healthy arm and the arm with acute CRPS I from 25 patients and from 30 healthy volunteers.
RESULTS: Levels of IL-8 and sTNFR I/II were significantly elevated in patients, whereas all soluble forms of selectins were significantly suppressed. There was no significant difference in white blood cell count (WBC), CRP, and IL-6. Substance P was significantly elevated in patients. The other two neuropeptides were unchanged. None of the parameters studied showed any differences between the CRPS I-affected arm and the normal arm.
CONCLUSIONS: Elevated IL-8 and sTNFR I/II levels indicate an association between CRPS I and an inflammatory process. Normal WBC, CRP, and IL-6 give evidence for localized inflammation. The hypothesis of neurogenic-induced inflammation mediated by neuropeptides is supported by elevated substance P levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514322     DOI: 10.1097/01.ajp.0000169669.70523.f0

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  55 in total

Review 1.  CRPS I following artificial disc surgery: case report and review of the literature.

Authors:  S M Knoeller; M Ehmer; B Kleinmann; T Wolter
Journal:  Eur Spine J       Date:  2011-01-28       Impact factor: 3.134

2.  Skin sympathetic function in complex regional pain syndrome type 1.

Authors:  Anupama Poudel; Masato Asahina; Yoshikatsu Fujinuma; Yoshitaka Yamanaka; Akira Katagiri; Nobuyuki Araki; Shigeki Hirano; Satoshi Kuwabara
Journal:  Clin Auton Res       Date:  2015-09-15       Impact factor: 4.435

Review 3.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 4.  Status of immune mediators in complex regional pain syndrome type I.

Authors:  Christian Schinkel; Martin H Kirschner
Journal:  Curr Pain Headache Rep       Date:  2008-06

5.  Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.

Authors:  Tian-Zhi Guo; Tzuping Wei; Wen-Wu Li; Xiang-Qi Li; J David Clark; Wade S Kingery
Journal:  J Pain       Date:  2014-07-22       Impact factor: 5.820

Review 6.  Clinical features and pathophysiology of complex regional pain syndrome.

Authors:  Johan Marinus; G Lorimer Moseley; Frank Birklein; Ralf Baron; Christian Maihöfner; Wade S Kingery; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

7.  Gardner-Diamond syndrome associated with complex regional pain syndrome.

Authors:  Lara K Edinger; Robert J Schwartzman
Journal:  J Dermatol Case Rep       Date:  2013-03-30

8.  Changes resembling complex regional pain syndrome following surgery and immobilization.

Authors:  Alison Pepper; Wenwu Li; Wade S Kingery; Martin S Angst; Catherine M Curtin; J David Clark
Journal:  J Pain       Date:  2013-02-28       Impact factor: 5.820

Review 9.  Complex regional pain syndrome in children: asking the right questions.

Authors:  Kenneth R Goldschneider
Journal:  Pain Res Manag       Date:  2012 Nov-Dec       Impact factor: 3.037

10.  Effective dosage and administration schedule of oral alendronate for non-nociceptive symptoms in rats with chronic constriction injury.

Authors:  Sun Im; Seong-Hoon Lim; Jong-In Lee; Young-Jin Ko; Joo Hyun Park; Bo-Young Hong; Geun-Young Park
Journal:  J Korean Med Sci       Date:  2010-05-25       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.